FEMININE SEXUAL & UROGYNECOLOGICAL Care

Decreased vaginal lubrication is an important feature of aging, hormonal imbalance & stress.  This important symptom often goes unnoticed in conventional care beyond band-aid approaches of  lubricants. While lubricants offer momentary help, they do not improve one's own vaginal 

source de joie moisture.

Dr. Parker is currently prescribing the VFit Plus in combination with hormones and peptides to patients with vaginal dryness & laxity in order to determine how significantly these symptoms can resolve using this innovative therapy.  So far, several of our patients have reported improvement in vaginal lubrication, sexual confidence, increased sensation & improved cosmetic appearance of the vagina.  To date, we have even received a few thank you notes from these women and their partners :)

 Vulvovaginitis is generally referred to gynecology to aide in diagnosis. Once diagnosis is confirmed, adjunctive treatments using diet, medication and supplements are used as an important aspect of a woman's treatment plan.  Ongoing pain may signify underlying conditions which need to be further evaluated to obtain proper diagnosis. Preventive prescriptions for previously diagnosed sexually transmitted conditions are written on a continuity of care basis.  Active sexually transmitted conditions are referred to gynecology. 

Female sexual arousal is an exquisitely complex system, and healthy sexuality is one aspect of overall health.    Yes, "it's chemical": sexual responses are mediated by neurotransmitters and neuropeptides, including oxytocin, norepineprine, dopamine, serotonin, endocanabinoids and melanocortins.  And yet one's sexual response is more than just chemical soup, as emotional, psychosocial, hormonal and metabolic factors all impact the relay systems involved with drive, receptivity and arousal. There are several types of sexual arousal disorders, including hyposexual arousal, female genital arousal, persistent genital arousal & female orgasm disorder.  Several classes of drugs are known to interfere with arousal, desire and orgasm. Coming as no surprise to women, sexual confidence, stress and self-image impact desire and arousal.    

We offer several adjunctive treatment options based upon a woman's health and individual goals.   Integrative treatment options include empowering education modules, prescription therapy,  peptide therapies, hormonal therapy with female steroid hormones and topical androgens where appropriate, low-level laser light therapy and lifestyle + couples counseling.    

 Medically known as vulvovaginal atrophy, a condition of gradual shrinking of vaginal tissue affects up to 84% of menopausal women over time.  The physiological and psychological toll this condition takes on the majority of these women is tantamount. Women diagnosed with sexual dysfunction are four times more likely to have vaginal atrophy.  Vaginal atrophy and laxity can occur due to any condition which causes estrogenic decline, and should be ruled out with a clinical evaluation. These include hypothalamic amenorrhea, primary ovarian failure, prolonged post-partum lactation, gonadotrophin-releasing hormone therapy and estrogen-antagonizing therapy such as progestin treatment can all impact vaginal atrophy.   For some women, atrophic changes can progress into vaginal stricture, making penetration painful if not impossible.  Thank goodness that there are increased treatment options available for VVA.  Pelvic floor therapy and dialators, combined with topical therapy, often produce encouraging results when used on a regular basis.   

Pelvic floor therapy, peptide therapy, vaginal estrogen, intravaginal dehydoepiandrosterone, vaginal lubricants and moisturizers can all work together for synergistic benefit. Effects are dose dependent, and we are here to help you maximize results from these options using 

a personalized care approach.

Incontinence is extremely common in women as they age, and yet at least 50% of women who experience incontinence do not seek out medical treatment.  There are a number of medications and lifestyle changes which may be useful in treating incontinence.  

There are three types of incontinence: stress, urgency and mixed, each meriting its own form of care.  Risk factors include increased age, insulin resistance, obesity, weight gain, history of giving birth, history of hysterectomy and depression.  Stress incontinence may be improved by strengthening the urethral sphincter and other factors. Urgency incontinence is a feature of overactive bladder syndrome. In overweight women, weight loss can reduce incontinence episodes by up to 70%.  The sooner that a woman works on addressing incontinence, the better the outcome can be. Please contact us for details.

Women's health needs to be based on listening to, rather than dismissing, the signs and cues that women's bodies are sending them.  PMS, excruciatingly painful periods, frequent periods, infrequent periods and heavy bleeding are all conditions which are feedback systems from our bodies, and all of these conditions may be  improved using integrative medicine.    Women with endometriosis have had their severe pelvic pain dismissed for four to eleven years, on average, before their concerns are taken seriously enough to permit them to be properly evaluated.    Many women coming to us have been on the birth control pill and are in search of alternatives.  Women who are on hormone replacement and experiencing bleeding may need further assessment or a change in medication dosing.  We are committed to collaborate with gynecologists and endometriosis surgical experts to provide individualized care to each woman throughout her journey towards a life with freedom from pelvic pain, PCOS, endometriosis, luteal phase defects, heavy bleeding, premenstrual dysphoric disorder and PMS.  

Genitourinary syndrome of menopause degrades the bladder, ureters and urethra in correlation with estrogen decline. Symptoms include increased bouts of painful urination, urgency and recurrent urinary tract infections.  Metabolic conditions such as insulin resistance predispose women towards urinary tract infections with non-classical symptoms.  

Differential diagnosis includes blood and urine testing using quantitative polymerase chain reaction (qPCR) -based urinary pathogen detection, which  provides a superior diagnostic method for UTI detection to conventional culture-based method.  Antibiotic resistance gene detection is used for a precision approach towards caring for the urethral microbiome. Interventional and preventive treatments are available.  Many urological cases are referred to a urologist to refine working diagnoses prior to solidifying integrative medical treatment options.